Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Zhaohui Liu MD"'
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Background For advanced hepatocellular carcinoma (HCC), sorafenib remains the established therapy. PD-1/PD-L1 inhibitors plus antiangiogenic drugs (PIAD) as a new therapeutic approach for advanced HCC is still a subject of clinical debate regarding w
Externí odkaz:
https://doaj.org/article/0e1de04f1f014ea3a2e6c3df301f1429
